AMEX:LABD   Direxion Daily S&P Biotech Bear 3X Shares
Since LABU Long cut short this week from the previous analysis (ran up 15% and stopped at 3% profit). Entering LABD Long as the next big idea for 5:1 R:R.

Fundamentally, I felt this was the right trade long before once the pharmy companies come out with official vaccines that will leave the majority of the industry in despair as only a select few in the industry will continue to benefit from the Covid story.

Ide yang Berhubungan

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.